We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03497767
Brief Title: A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases (OUTRUN)

First Submitted : February 26, 2018
First Submitted that Met QC Criteria : April 12, 2018
First Posted : April 13, 2018

Last Update Submitted that Met QC Criteria : November 16, 2022
Last Update Posted : November 21, 2022